Doxercalciferol D6
| Product Name | Doxercalciferol D6 |
|---|---|
| Alternate Names | Doxercalciferol Stable Isotopes, Stable Isotopes of Doxercalciferol |
| CAT No. | CS-O-06565 |
| CAS No. | 54573-75-0(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 418.68 g/mol |
| Mol. For. | C28H38D6O2 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Doxercalciferol |
| Purity | >98% |
| Therapeutic | Vitamins |
| Smileys | C[C@]([C@@]1([H])[C@H](C)/C=C/[C@H](C)C(C([2H])([2H])[2H])C([2H])([2H])[2H])(CCC/2)[C@](CC1)([H])C2=C\C=C(C[C@@H](O)C[C@@H]3O)/C3=C |
| Canonical Smiles | CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C |
| InchIKey | HKXBNHCUPKIYDM-CGMHZMFXSA-N |
| Inchl | InChI=1S/C28H44O2/c1-18(2)19(3)9-10-20(4)25-13-14-26-22(8-7-15-28(25,26)6)11-12-23-16-24(29)17-27(30)21(23)5/h9-12,18-20,24-27,29-30H,5,7-8,13-17H2,1-4,6H3/b10-9+,22-11+,23-12-/t19-,20+,24+,25+,26-,27-,28+/m0/s1 |
| IUPAC | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Doxercalciferol D6 is a synthetic form of vitamin D3 that is primarily used for treating secondary hyperparathyroidism in patients with chronic kidney disease. This condition occurs when the parathyroid gland produces too much parathyroid hormone, leading to a number of complications including bone loss, muscle weakness, and cardiovascular disease. By regulating calcium and phosphorus levels in the body, doxercalciferol D6 helps to prevent these complications and improve overall health outcomes.
The chemical structure of doxercalciferol D6 is similar to that of natural vitamin D3, but with six deuterium atoms incorporated into its molecular structure. This makes it a useful tool for researchers studying the metabolism and pharmacokinetics of vitamin D3 in the body. Doxercalciferol D6 is typically administered orally, although it can also be given intravenously in certain cases.
As with all medications, doxercalciferol D6 has potential side effects that patients should be aware of. These can include nausea, vomiting, and headache, as well as more serious complications like high blood calcium levels and allergic reactions. Patients should always discuss the risks and benefits of any medication with their healthcare provider before starting treatment.
Overall, doxercalciferol D6 is an important tool in the management of secondary hyperparathyroidism and other conditions related to vitamin D deficiency. Its chemical properties make it a valuable resource for researchers studying the complex interactions between vitamin D3 and the body, and its use has the potential to greatly improve patient outcomes and quality of life.
Get an Instant Quote
Related Compounds
Doxercalciferol D3 |